Principal, Roivant Health at Roivant Sciences

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Market AnalysisCompetitive AnalysisStrategic PlanningDue DiligenceBiotechnologyDrug DiscoveryTechnology EvaluationBusiness Incubation

Questions & Answers

Common questions about this position

Is this position remote or does it require office work?

The position is primarily remote but may require occasional travel.

What is the salary for the Principal role at Roivant Health?

This information is not specified in the job description.

What does the company culture look like at Roivant Sciences?

Roivant embraces diversity and fosters an inclusive culture, valuing motivated people with diverse backgrounds and skillsets, while promoting an open and collaborative environment. They believe in rapid career advancement, flexible role design, and encourage calculated risk-taking.

What specific skills or experiences are required for this role?

This information is not specified in the job description.

What makes a strong candidate for this Principal position?

Roivant values motivated people with diverse backgrounds and skillsets who thrive in an open, collaborative environment and are open to calculated risk-taking, with flexible roles designed around individual strengths.

Roivant Sciences

Develops biopharmaceuticals and RNA therapeutics

About Roivant Sciences

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates in the biopharmaceutical market, which involves creating drugs from biological sources. Roivant's unique business model combines in-house development with strategic partnerships, allowing it to build a strong pipeline of drug candidates and utilize advanced technologies to meet medical needs. A key subsidiary, Genevant, specializes in RNA therapeutics, employing proprietary delivery platforms for mRNA, RNAi, and gene editing to treat specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

New York City, New YorkHeadquarters

2014Year Founded

$1,750.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Risks

Integration challenges from Dermavant acquisition may disrupt operations and delay development.

Regulatory hurdles in Pulmovant collaboration with Bayer could impede progress.

Failure of lupus drug brepocitinib may lead to financial losses and investor concerns.

Differentiation

Roivant Sciences focuses on late-stage drug candidates, reducing development time and cost.

The company builds Vants, nimble biotech firms, to enhance drug development efficiency.

Roivant leverages RNA therapeutics, including mRNA and RNAi, for innovative treatments.

Upsides

Roivant's acquisition of Dermavant expands its dermatology portfolio and therapeutic areas.

Strategic partnerships with Bayer and Roche accelerate drug development and market entry.

Increased investment from financial institutions highlights confidence in Roivant's growth potential.

Land your dream remote job 3x faster with AI

Try Jobo Free